as 06-20-2025 4:00pm EST
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | DENVER |
Market Cap: | 527.9M | IPO Year: | 2021 |
Target Price: | $5.00 | AVG Volume (30 days): | 32.0K |
Analyst Decision: | Sell | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.24 | EPS Growth: | N/A |
52 Week Low/High: | $2.60 - $6.69 | Next Earning Date: | 05-06-2025 |
Revenue: | $831,683,000 | Revenue Growth: | 12.19% |
Revenue Growth (this year): | 13.77% | Revenue Growth (next year): | 10.12% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ZORETIC RICHARD C | INNV | Director | May 28 '25 | Buy | $4.06 | 42,715 | $173,306.60 | 45,779 | |
ZORETIC RICHARD C | INNV | Director | May 21 '25 | Buy | $4.05 | 3,045 | $12,308.25 | 45,779 | |
ZORETIC RICHARD C | INNV | Director | May 16 '25 | Buy | $4.24 | 2,893 | $12,317.48 | 45,779 | |
SCARBROUGH MICHAEL ANTHONY | INNV | President and COO | May 9 '25 | Buy | $3.72 | 33,000 | $122,890.00 | 33,000 |
INNV Breaking Stock News: Dive into INNV Ticker-Specific Updates for Smart Investing
Argus Research
a day ago
Argus Research
3 days ago
Argus Research
4 days ago
Argus Research
5 days ago
Argus Research
8 days ago
Argus Research
9 days ago
Argus Research
10 days ago
Argus Research
11 days ago
The information presented on this page, "INNV InnovAge Holding Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.